<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T07:01:47Z</responseDate>
  <request identifier="oai:figshare.com:article/32628177" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32628177</identifier>
        <datestamp>2026-10-01T17:41:40Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>QUB-1475: A novel bioactive peptide from the skin secretion of frog Hylarana Guentheri</dc:title>
          <dc:creator>Jiewen Zheng (5684273)</dc:creator>
          <dc:subject>PUREID: 183470393</dc:subject>
          <dc:description>As antimicrobial resistance has become a threat towards human health for decades, the demand for the development of an alternative, broad-spectrum antimicrobial agent has turned into increasingly essential. As a consequence, the emergence of the antimicrobial peptide (AMP) derived from the skin secretion of amphibians has promoted the development of novel potential clinical therapeutics. Therefore, a novel potential bioactive peptide QUB-1475 derived from the frog species Hylarana guentheri was chosen here to get thoroughly studied. &lt;br&gt;In this research, the novel temporin-like peptide, with the sequence: FLQHIIGALGFIF-NH2, was discovered in the skin secretion of Hylarana guentheri. This thesis aimed to isolate and characterise the structure of the novel peptide QUB-1475 through “shotgun” molecular cloning, reverse-phase High-Performance Liquid Chromatography (RP-HPLC) and Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) analysis. Then the peptide was chemically-synthesised and evaluated through a series of bioactivity assays.&lt;br&gt;This peptide displayed no antimicrobial activity on S. aureus, E. coli and C. albicans conducted in this research. The IC50 values of the peptide towards NCI-H23 cell line, PC3 cell line and U-251 MG cell line are 26.51 μM, 10.03 μM, and 44.78 μM respectively. Moreover, it should be emphasised that the novel peptide presented haemolytic rate of 18.95% at the concentration of 512 μM. &lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis embargoed until 30th September 2024 &lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T17:41:40Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32628177.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/QUB-1475_A_novel_bioactive_peptide_from_the_skin_secretion_of_frog_Hylarana_Guentheri/32628177</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
